Causes and outcomes of the acute chest syndrome in sickle cell disease

New England Journal of Medicine

Volumn 342, Issue 25, 2000, Pages 1855-1865

  Vichinsky, Elliott P ^a   Neumayr, Lynne D ^a   Earles, Ann N ^a   Williams, Roger ^a   Lennette, Evelyne T ^b   Dean, Deborah ^c   Nickerson, Bruce ^d   Orringer, Eugene ^e   McKie, Virgil ^f   Bellevue, Rita ^g   Daeschner, Charles ^h   Manci, Elizabeth A ⁱ   Abboud, Miguel ^j   Moncino, Mark ^l   Ballas, Samir ^l   Ware, Russell ^k  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b Virolab Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f MEDICAL COLLEGE OF GEORGIA   (United States)

^g NEW YORK METHODIST HOSPITAL   (United States)

^h EAST CAROLINA UNIVERSITY   (United States)

ⁱ Department of Pathology   (United States)

^j MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^k DUKE UNIVERSITY MEDICAL CENTER   (United States)

^l Duke University Medical Center ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT;

ADULT; ARTICLE; BLOOD TRANSFUSION; BRONCHOPNEUMONIA; BRONCHOSCOPY; CAUSE OF DEATH; CLINICAL PROTOCOL; FEMALE; HUMAN; LUNG DISEASE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RESPIRATORY FAILURE; SICKLE CELL ANEMIA; SYNDROME; THORAX PAIN;

ACUTE DISEASE; ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; BRONCHODILATOR AGENTS; CHEST PAIN; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; EMBOLISM, FAT; FEMALE; HUMANS; INFECTION; LUNG DISEASES; MALE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY;

EID: 0034702282     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200006223422502     Document Type: Article

References (46)

1. Vichinsky E. Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Semin Hematol 1991;28:220-6.
2. Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in sickle cell disease: incidence and risk factors: the Cooperative Study of Sickle Cell Disease. Blood 1994;84:643-9.
3. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med 1994;330: 1639-44.
4. Castro O. Systemic fat embolism and pulmonary hypertension in sickle cell disease. Hematol Oncol Clin North Am 1996;10:1289-303.
5. Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med 1995;333:699-703.
6. Lowenthal EA, Wells A, Emanuel PD, Player R, Prchal JT. Sickle cell acute chest syndrome associated with parvovirus B19 infection: case series and review. Am J Hematol 1996;51:207-13.
7. Miller ST, Hammerschlag MR, Chirgwin K, et al. Role of Chlamydia pneumoniae in acute chest syndrome of sickle cell disease. J Pediatr 1991; 118:30-3.
8. Poncz M, Kane E, Gill FM. Acute chest syndrome in sickle cell disease: etiology and clinical correlates. J Pediatr 1985;107:861-6.
9. Sprinkle RH, Cole T, Smith S, Buchanan GR. Acute chest syndrome in children with sickle cell disease: a retrospective analysis of 100 hospitalized cases. Am J Pediatr Hematol Oncol 1986;8:105-10.
10. Kirkpatrick MB, Haynes J Jr, Bass JB Jr. Results of bronchoscopically obtained lower airway cultures from adult sickle cell disease patients with the acute chest syndrome. Am J Med 1991;90:206-10.
11. Vichinsky E, Williams R, Das M, et al. Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood 1994;83:3107-12.
12. Godeau B, Schaeffer A, Bachier D, et al. Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: value for diagnostic assessment of fat embolism. Am J Respir Crit Care Med 1996;153:1691-6.
13. Hutchinson RM, Merrick MV, White JM. Fat embolism in sickle cell disease. J Clin Pathol 1973;26:620-2.
14. Landry ML, Hsiung GD. Primary isolation of viruses. In: Specter S, Lancz G, eds. Clinical virology manual. 2nd ed. New York: Elsevier Science Publishing, 1992:43-69.
15. Waites KB, Taylor-Robinson D. Mycoplasma and Ureaplasma. In: Murray PR, ed. Manual of clinical microbiology. 7th ed. Washington, D.C.: ASM Press, 1999:782-806.
16. Lennette ET, Lennette DA. Immune adherence hemagglutination. In: Specter S, Lancz G, eds. Clinical virology manual. 2nd ed. New York: Elsevier Science Publishing, 1992:251-61.
17. Kajigaya S, Shimada T, Fujita S, Young NS. A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus. Proc Natl Acad Sci U S A 1989;86:7601-5.
18. Lennette ET. Epstein-Barr virus. In: Murray PR, ed. Manual of clinical microbiology. 7th ed. Washington, D.C.: ASM Press, 1999:912-8.
19. Schachter J. Chlamydiae. In: Balows A, Hausler WJ Jr, Hermann KL, Isenberg HD, Shadomy HJ, eds. Manual of clinical microbiology. 5th ed. Washington, D.C.: ASM Press, 1991:1045-53.
20. Lietman T, Brooks D, Moncada J, Schachter J, Dawson C, Dean D. Chronic follicular conjunctivitis associated with Chlamydia psittaci or Chlamydia pneumoniae. Clin Infect Dis 1998;26:1335-40.
21. Powars D, Weidman JA, Odom-Maryon T, Niland JC, Johnson C. Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine (Baltimore) 1988;67:66-76.
22. Vichinsky EP, Styles LA, Colangelo LH, Wright EC, Castro O, Nickerson B. Acute chest syndrome in sickle cell disease: clinical presentation and course: Cooperative Study of Sickle Cell Disease. Blood 1997;89: 1787-92.
23. Styles LA, Schalkwijk CG, Aarsman AJ, Vichinsky EP, Lubin BH, Kuypers FA. Phospholipase A2 levels in acute chest syndrome of sickle cell disease. Blood 1996;87:2573-8.
24. Bone RC, Balk R, Slotman G, et al. Adult respiratory distress syndrome: sequence and importance of development of multiple organ failure. Chest 1992;101:320-6.
25. Jacobs ER, Bone RC. Clinical indicators in sepsis and septic adult respiratory distress syndrome. Med Clin North Am 1986;70:921-32.
26. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998;129:433-40.
27. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998;91:288-94.
28. Prohovnik I, Pavlakis SG, Piomelli S, et al. Cerebral hyperemia, stroke, and transfusion in sickle cell disease. Neurology 1989;39:344-8.
29. Tohgi H, Suzuki H, Tamura K, Kimura B. Platelet volume, aggregation, and adenosine triphosphate release in cerebral thrombosis. Stroke 1991;22:17-21.
30. Kohelet D, Perman M, Hanna G, Ballin A. Reduced platelet counts in neonatal respiratory distress syndrome. Biol Neonate 1990;57:334-42.
31. Cook PJ, Honeybourne D, Lip GY, Beevers DG, Wise R, Davies P. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke 1998;29:404-10.
32. Narita M, Matsuzono Y, Togashi T, Kajii N. DNA diagnosis of central nervous system infection by Mycoplasma pneumoniae. Pediatrics 1992;90: 250-3.
33. Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease: the Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med 1995;333:206-13.
34. Mallouh AA, Asha M. Beneficial effect of blood transfusion in children with sickle cell chest syndrome. Am J Dis Child 1988;142:178-82.
35. Emre U, Miller ST, Gutierez M, Steiner P, Rao SP, Rao M. Effect of transfusion in acute chest syndrome of sickle cell disease. J Pediatr 1995; 127:901-4.
36. Wyncoll DL, Evans TW. Acute respiratory distress syndrome. Lancet 1999;354:497-501.
37. Chastre J, Fagon JY, Soler P, et al. Bronchoalveolar lavage for rapid diagnosis of the fat embolism syndrome in trauma patients. Ann Intern Med 1990;130:583-8.
38. Frankel LR, Smith DW, Lewiston NJ. Bronchoalveolar lavage for diagnosis of pneumonia in the immunocompromised child. Pediatrics 1988; 81:785-8.
39. Bates JH, Campbell GD, Barron AL, et al. Microbial etiology of acute pneumonia in hospitalized patients. Chest 1992;101:1005-12.
40. Chirgwin K, Roblin PM, Gelling M, Hammerschlag MR, Schachter J. Infection with Chlamydia pneumoniae in Brooklyn. J Infect Dis 1991;163: 757-61.
41. Smolinski PA, Offermann MK, Eckman JR, Wick TM. Double-stranded RNA induces sickle erythrocyte adherence to endothelium: a potential role for viral infection in vaso-occlusive pain episodes in sickle cell anemia. Blood 1995;85:2945-50.
42. Aldrich TK, Dhuper SK, Patwa NS, et al. Pulmonary entrapment of sickle cells: the role of regional alveolar hypoxia. J Appl Physiol 1996;80: 531-9.
43. Hebbel RP, Visser MR, Goodman JL, Jacob HS, Vercellotti GM. Potentiated adherence of sickle erythrocytes to endothelium infected by virus. J Clin Invest 1987;80:1503-6.
44. Ibe BO, Morris J, Kurantsin-Mills J, Raj JU. Sickle erythrocytes induce prostacyclin and thromboxane synthesis by isolated perfused rat lungs. Am J Physiol 1997;272:L597-L602.
45. Gladwin MT, Schechter AN, Shelhamer JH, Ognibene FP The acute chest syndrome in sickle cell disease: possible role of nitric oxide in its pathophysiology and treatment. Am J Respir Crit Care Med 1999;159:1368-76.
46. Bernini JC, Rogers ZR, Sandler ES, Reisch JS, Quinn CT, Buchanan GR. Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood 1998;92:3082-9.